Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 6 April 2018 Disclosure of Outstanding Voting Securities Regulated information 5 April 2018 Biocartis announces publication of its 2017 annual report Regulated information 15 March 2018 Biocartis Abstract on Performance Idylla™ ctRAS Liquid Biopsy Tests Selected for Oral Presentation at 2018 American Association for Cancer Research Meeting Non-regulated information 1 March 2018 European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects Inside information Regulated information 1 March 2018 Biocartis Establishes R&D Center in the US Biocartis team strengthened with joining of the Janssen Idylla™ assay development team Non-regulated information 1 March 2018 Biocartis Announces 2017 Results and 2018 Outlook Regulated information 27 February 2018 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information 22 February 2018 Biocartis to host Webcast for Announcement 2017 Financial Results on 1 March 2018 Regulated information 24 January 2018 Biocartis & Immunexpress Sign Partnership for a Sepsis Host Immune Response Test on the Idylla™ platform Non-regulated information 12 January 2018 Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Regulated information Pagination First page « First Previous page ‹‹ … Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Page 26 Page 27 … Next page ›› Last page Last »